[FG] Pfister Marc
Head of Research Unit
Prof. Dr. med.Marc Pfister
Publications
267 found
Show per page
Ravix, A. et al. (2025) ‘Dose Evaluation and Optimization of Amoxicillin in Children Treated for Lyme Disease’, The Journal of Clinical Pharmacology [Preprint]. Available at: https://doi.org/10.1002/jcph.6190.
Ravix, A. et al. (2025) ‘Dose Evaluation and Optimization of Amoxicillin in Children Treated for Lyme Disease’, The Journal of Clinical Pharmacology [Preprint]. Available at: https://doi.org/10.1002/jcph.6190.
Bräm, D. et al. (2025) ‘Understanding and Streamlining Dose Finding: From Dose Simulation to Dose Estimation’, Journal of Clinical Pharmacology [Preprint]. Available at: https://doi.org/10.1002/jcph.6188.
Bräm, D. et al. (2025) ‘Understanding and Streamlining Dose Finding: From Dose Simulation to Dose Estimation’, Journal of Clinical Pharmacology [Preprint]. Available at: https://doi.org/10.1002/jcph.6188.
Bräm, D.S. et al. (2025) ‘Low-dimensional neural ordinary differential equations accounting for inter-individual variability implemented in Monolix and NONMEM’, CPT: Pharmacometrics and Systems Pharmacology, 14(1), pp. 5–16. Available at: https://doi.org/10.1002/psp4.13265.
Bräm, D.S. et al. (2025) ‘Low-dimensional neural ordinary differential equations accounting for inter-individual variability implemented in Monolix and NONMEM’, CPT: Pharmacometrics and Systems Pharmacology, 14(1), pp. 5–16. Available at: https://doi.org/10.1002/psp4.13265.
Bachmann, Freya et al. (2024) ‘Computing optimal drug dosing regarding efficacy and safety: the enhanced OptiDose method in NONMEM’, Journal of Pharmacokinetics and Pharmacodynamics, 51(6), pp. 919–934. Available at: https://doi.org/10.1007/s10928-024-09940-9.
Bachmann, Freya et al. (2024) ‘Computing optimal drug dosing regarding efficacy and safety: the enhanced OptiDose method in NONMEM’, Journal of Pharmacokinetics and Pharmacodynamics, 51(6), pp. 919–934. Available at: https://doi.org/10.1007/s10928-024-09940-9.
Welzel, Tatjana et al. (2024) ‘Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases’, Pediatric Rheumatology, 22(1). Available at: https://doi.org/10.1186/s12969-023-00930-8.
Welzel, Tatjana et al. (2024) ‘Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases’, Pediatric Rheumatology, 22(1). Available at: https://doi.org/10.1186/s12969-023-00930-8.
Ajayi, David T. et al. (2024) ‘Pharmacometric Analysis to Describe Pharmacokinetics and Exposure‐Efficacy Response of Ivermectin in Adolescents Infected with Trichuris trichiura’, The Journal of Clinical Pharmacology [Preprint]. Available at: https://doi.org/10.1002/jcph.6158.
Ajayi, David T. et al. (2024) ‘Pharmacometric Analysis to Describe Pharmacokinetics and Exposure‐Efficacy Response of Ivermectin in Adolescents Infected with Trichuris trichiura’, The Journal of Clinical Pharmacology [Preprint]. Available at: https://doi.org/10.1002/jcph.6158.
Muff, Rafael et al. (2024) ‘Serum Sodium Concentration During Arginine Vasopressin Infusion in Critically Ill Children’, Children, 11(11), p. 1359. Available at: https://doi.org/10.3390/children11111359.
Muff, Rafael et al. (2024) ‘Serum Sodium Concentration During Arginine Vasopressin Infusion in Critically Ill Children’, Children, 11(11), p. 1359. Available at: https://doi.org/10.3390/children11111359.
Leutheuser, Heike et al. (2024) ‘Predicting risk for nocturnal hypoglycemia after physical activity in children with type 1 diabetes’, Frontiers in Medicine, 11. Available at: https://doi.org/10.3389/fmed.2024.1439218.
Leutheuser, Heike et al. (2024) ‘Predicting risk for nocturnal hypoglycemia after physical activity in children with type 1 diabetes’, Frontiers in Medicine, 11. Available at: https://doi.org/10.3389/fmed.2024.1439218.
Gavel, Gil et al. (2024) ‘Understanding time to peak effect of propofol as sole agent on bispectral index in children aged 2–12 years’, Pediatric Anesthesia, 34(10), pp. 1019–1028. Available at: https://doi.org/10.1111/pan.14972.
Gavel, Gil et al. (2024) ‘Understanding time to peak effect of propofol as sole agent on bispectral index in children aged 2–12 years’, Pediatric Anesthesia, 34(10), pp. 1019–1028. Available at: https://doi.org/10.1111/pan.14972.
Golhen, Klervi et al. (2024) ‘Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg’, Pharmaceutics, 16(9), p. 1186. Available at: https://doi.org/10.3390/pharmaceutics16091186.
Golhen, Klervi et al. (2024) ‘Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg’, Pharmaceutics, 16(9), p. 1186. Available at: https://doi.org/10.3390/pharmaceutics16091186.
Bräm, D.S. et al. (2024) ‘Applying Neural ODEs to Derive a Mechanism-Based Model for Characterizing Maturation-Related Serum Creatinine Dynamics in Preterm Newborns’, Journal of Clinical Pharmacology, 64(9), pp. 1141–1149. Available at: https://doi.org/10.1002/jcph.2460.
Bräm, D.S. et al. (2024) ‘Applying Neural ODEs to Derive a Mechanism-Based Model for Characterizing Maturation-Related Serum Creatinine Dynamics in Preterm Newborns’, Journal of Clinical Pharmacology, 64(9), pp. 1141–1149. Available at: https://doi.org/10.1002/jcph.2460.
Anliker‐Ort, Marion et al. (2024) ‘Pharmacokinetics‐Based Pediatric Dose Evaluation and Optimization Using Saliva – A Case Study’, The Journal of Clinical Pharmacology, 64(7), pp. 810–819. Available at: https://doi.org/10.1002/jcph.2428.
Anliker‐Ort, Marion et al. (2024) ‘Pharmacokinetics‐Based Pediatric Dose Evaluation and Optimization Using Saliva – A Case Study’, The Journal of Clinical Pharmacology, 64(7), pp. 810–819. Available at: https://doi.org/10.1002/jcph.2428.
Anliker‐Ort, Marion et al. (2024) ‘Pharmacokinetics-Based Pediatric Dose Evaluation and Optimization Using Saliva – A Case Study’, Journal of Clinical Pharmacology, 64(7), pp. 810–819. Available at: https://doi.org/10.1002/jcph.2428.
Anliker‐Ort, Marion et al. (2024) ‘Pharmacokinetics-Based Pediatric Dose Evaluation and Optimization Using Saliva – A Case Study’, Journal of Clinical Pharmacology, 64(7), pp. 810–819. Available at: https://doi.org/10.1002/jcph.2428.
Fenner, A. et al. (2024) ‘Antibiotic Exposure of Critically Ill Children at a Tertiary Care Paediatric Intensive Care Unit in Switzerland’, Children, 11(6). Available at: https://doi.org/10.3390/children11060731.
Fenner, A. et al. (2024) ‘Antibiotic Exposure of Critically Ill Children at a Tertiary Care Paediatric Intensive Care Unit in Switzerland’, Children, 11(6). Available at: https://doi.org/10.3390/children11060731.
Pillay-Fuentes Lorente, Veshni et al. (2024) ‘Understanding Drug Exposure and Trichuris trichiura Cure Rates: A Pharmacometric Approach for Albendazole-Ivermectin Co-medication in Tanzania and Côte d’Ivoire’, Drugs in R&D, 24(2), pp. 331–340. Available at: https://doi.org/10.1007/s40268-024-00476-4.
Pillay-Fuentes Lorente, Veshni et al. (2024) ‘Understanding Drug Exposure and Trichuris trichiura Cure Rates: A Pharmacometric Approach for Albendazole-Ivermectin Co-medication in Tanzania and Côte d’Ivoire’, Drugs in R&D, 24(2), pp. 331–340. Available at: https://doi.org/10.1007/s40268-024-00476-4.
Dao, Kim et al. (2024) ‘Novel Patient‐Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use’, The Journal of Clinical Pharmacology. 30.05.2024, 64(10), pp. 1295–1303. Available at: https://doi.org/10.1002/jcph.2462.
Dao, Kim et al. (2024) ‘Novel Patient‐Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use’, The Journal of Clinical Pharmacology. 30.05.2024, 64(10), pp. 1295–1303. Available at: https://doi.org/10.1002/jcph.2462.
Gotta, Verena et al. (2024) ‘Pharmacometric in silico studies used to facilitate a national dose standardisation process in neonatology – application to amikacin’, Swiss Medical Weekly, 154(4), p. 3632. Available at: https://doi.org/10.57187/s.3632.
Gotta, Verena et al. (2024) ‘Pharmacometric in silico studies used to facilitate a national dose standardisation process in neonatology – application to amikacin’, Swiss Medical Weekly, 154(4), p. 3632. Available at: https://doi.org/10.57187/s.3632.
Bräm, Dominic Stefan et al. (2024) ‘Low-dimensional neural ODEs and their application in pharmacokinetics’, Journal of Pharmacokinetics and Pharmacodynamics, 51(2), pp. 123–140. Available at: https://doi.org/10.1007/s10928-023-09886-4.
Bräm, Dominic Stefan et al. (2024) ‘Low-dimensional neural ODEs and their application in pharmacokinetics’, Journal of Pharmacokinetics and Pharmacodynamics, 51(2), pp. 123–140. Available at: https://doi.org/10.1007/s10928-023-09886-4.
Gotta, Verena et al. (2024) ‘Pharmacometric in silico studies used to facilitate a national dose standardisation process in neonatology - application to amikacin’, Swiss Medical Weekly, 154(4). Available at: https://doi.org/10.57187/s.3632.
Gotta, Verena et al. (2024) ‘Pharmacometric in silico studies used to facilitate a national dose standardisation process in neonatology - application to amikacin’, Swiss Medical Weekly, 154(4). Available at: https://doi.org/10.57187/s.3632.
Lass, Jana et al. (2024) ‘Pharmacokinetics of oral spironolactone in infants up to 2 years of age’, European Journal of Clinical Pharmacology, 80(2), pp. 239–248. Available at: https://doi.org/10.1007/s00228-023-03599-w.
Lass, Jana et al. (2024) ‘Pharmacokinetics of oral spironolactone in infants up to 2 years of age’, European Journal of Clinical Pharmacology, 80(2), pp. 239–248. Available at: https://doi.org/10.1007/s00228-023-03599-w.
Ulziibat, M. et al. (2024) ‘Microbiological Spectrum of Osteoarticular Infections and Their Management in Mongolian Children’, Global Pediatric Health, 11. Available at: https://doi.org/10.1177/2333794X241298801.
Ulziibat, M. et al. (2024) ‘Microbiological Spectrum of Osteoarticular Infections and Their Management in Mongolian Children’, Global Pediatric Health, 11. Available at: https://doi.org/10.1177/2333794X241298801.
Villaverde, Serena MD*,† et al. (2024) ‘Antiviral Treatment and Risk of Hearing Loss in Asymptomatic and Mild Symptomatic Infants With Congenital Cytomegalovirus’, Pediatric Infectious Disease Journal [Preprint]. Available at: https://doi.org/10.1097/inf.0000000000004583.
Villaverde, Serena MD*,† et al. (2024) ‘Antiviral Treatment and Risk of Hearing Loss in Asymptomatic and Mild Symptomatic Infants With Congenital Cytomegalovirus’, Pediatric Infectious Disease Journal [Preprint]. Available at: https://doi.org/10.1097/inf.0000000000004583.
Ehlers, Lisa et al. (2023) ‘Treat-to-target strategies for the management of familial Mediterranean Fever in children’, Pediatric Rheumatology, 21(1). Available at: https://doi.org/10.1186/s12969-023-00875-y.
Ehlers, Lisa et al. (2023) ‘Treat-to-target strategies for the management of familial Mediterranean Fever in children’, Pediatric Rheumatology, 21(1). Available at: https://doi.org/10.1186/s12969-023-00875-y.
Anliker-Ort, Marion et al. (2023) ‘Modeling time-delayed concentration-QT effects with ACT-1014-6470, a novel oral complement factor 5a receptor 1 (C5a1 receptor) antagonist’, Pharmacology Research and Perspectives, 11(4). Available at: https://doi.org/10.1002/prp2.1112.
Anliker-Ort, Marion et al. (2023) ‘Modeling time-delayed concentration-QT effects with ACT-1014-6470, a novel oral complement factor 5a receptor 1 (C5a1 receptor) antagonist’, Pharmacology Research and Perspectives, 11(4). Available at: https://doi.org/10.1002/prp2.1112.
Satirer, Özlem et al. (2023) ‘Cryopyrin-assoziierte periodische Syndrome’, Arthritis und Rheuma, 43(04), pp. 264–274. Available at: https://doi.org/10.1055/a-2114-0449.
Satirer, Özlem et al. (2023) ‘Cryopyrin-assoziierte periodische Syndrome’, Arthritis und Rheuma, 43(04), pp. 264–274. Available at: https://doi.org/10.1055/a-2114-0449.
Bachmann, Freya et al. (2023) ‘Computing optimal drug dosing with OptiDose: implementation in NONMEM’, Journal of Pharmacokinetics and Pharmacodynamics, 50(3), pp. 173–188. Available at: https://doi.org/10.1007/s10928-022-09840-w.
Bachmann, Freya et al. (2023) ‘Computing optimal drug dosing with OptiDose: implementation in NONMEM’, Journal of Pharmacokinetics and Pharmacodynamics, 50(3), pp. 173–188. Available at: https://doi.org/10.1007/s10928-022-09840-w.
Weber, A.N.R. et al. (2023) ‘Comment on: Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3: Reply’, Rheumatology (United Kingdom), 62(5), pp. E168–E169. Available at: https://doi.org/10.1093/rheumatology/keac718.
Weber, A.N.R. et al. (2023) ‘Comment on: Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3: Reply’, Rheumatology (United Kingdom), 62(5), pp. E168–E169. Available at: https://doi.org/10.1093/rheumatology/keac718.
Golhen K et al. (2023) ‘Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and Children’, Pharmaceutics, 15(4). Available at: https://doi.org/10.3390/pharmaceutics15041033.
Golhen K et al. (2023) ‘Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and Children’, Pharmaceutics, 15(4). Available at: https://doi.org/10.3390/pharmaceutics15041033.
Golhen, Klervi et al. (2023) ‘Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and Children’, Pharmaceutics, 15(4), p. 1033. Available at: https://doi.org/10.3390/pharmaceutics15041033.
Golhen, Klervi et al. (2023) ‘Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and Children’, Pharmaceutics, 15(4), p. 1033. Available at: https://doi.org/10.3390/pharmaceutics15041033.
Welzel, T., Woerner, A. and Kaiser, D. (2023) ‘Arthrite juvénile idiopathique systémique, une mise au point’, Paediatrica, 35(1). Available at: https://doi.org/10.35190/paediatrica.f.2024.1.4.
Welzel, T., Woerner, A. and Kaiser, D. (2023) ‘Arthrite juvénile idiopathique systémique, une mise au point’, Paediatrica, 35(1). Available at: https://doi.org/10.35190/paediatrica.f.2024.1.4.
Smit, C. et al. (2023) ‘Oral Ibuprofen Is More Effective than Intravenous Ibuprofen for Closure of a Patent Ductus Arteriosus: Can Pharmacokinetic Modeling Help Us to Understand Why?’, Neonatology, 120(1), pp. 81–89. Available at: https://doi.org/10.1159/000526210.
Smit, C. et al. (2023) ‘Oral Ibuprofen Is More Effective than Intravenous Ibuprofen for Closure of a Patent Ductus Arteriosus: Can Pharmacokinetic Modeling Help Us to Understand Why?’, Neonatology, 120(1), pp. 81–89. Available at: https://doi.org/10.1159/000526210.
Marx, Alexander et al. (2023) ‘Blood glucose forecasting from temporal and static information in children with T1D’, Frontiers in Pediatrics, 11. Available at: https://doi.org/10.3389/fped.2023.1296904.
Marx, Alexander et al. (2023) ‘Blood glucose forecasting from temporal and static information in children with T1D’, Frontiers in Pediatrics, 11. Available at: https://doi.org/10.3389/fped.2023.1296904.
Deichmann, Julia et al. (2023) ‘New model of glucose-insulin regulation characterizes effects of physical activity and facilitates personalized treatment evaluation in children and adults with type 1 diabetes’, PLoS Computational Biology, 19(2). Available at: https://doi.org/10.1371/journal.pcbi.1010289.
Deichmann, Julia et al. (2023) ‘New model of glucose-insulin regulation characterizes effects of physical activity and facilitates personalized treatment evaluation in children and adults with type 1 diabetes’, PLoS Computational Biology, 19(2). Available at: https://doi.org/10.1371/journal.pcbi.1010289.
Buettcher, Michael et al. (2023) ‘National survey in Switzerland calls for improved diagnosis and treatment in children with scabies’, Swiss Medical Weekly. 22.11.2023, 153(11). Available at: https://doi.org/10.57187/SMW.2023.40129.
Buettcher, Michael et al. (2023) ‘National survey in Switzerland calls for improved diagnosis and treatment in children with scabies’, Swiss Medical Weekly. 22.11.2023, 153(11). Available at: https://doi.org/10.57187/SMW.2023.40129.
Buettcher, M and Marquez, L (2023) ‘Toxoplasmosis ESPID Education Online Course: Congenital and Perinatal Infections’, ESPID Education Online Course: Congenital and Perinatal Infections. Available at: https://education.espid.org/espid/2022/congenital-and-perinatal-infection-course/350945/faculty.presenters.module.1.introduction.html?f=menu%3D24%2Abrowseby%3D3%2Asortby%3D2%2Ace_id%3D2216%2Amarker%3D1673%2Afeatured%3D18019%2Ashow_banner_in_top_panel%3D1 .
Buettcher, M and Marquez, L (2023) ‘Toxoplasmosis ESPID Education Online Course: Congenital and Perinatal Infections’, ESPID Education Online Course: Congenital and Perinatal Infections. Available at: https://education.espid.org/espid/2022/congenital-and-perinatal-infection-course/350945/faculty.presenters.module.1.introduction.html?f=menu%3D24%2Abrowseby%3D3%2Asortby%3D2%2Ace_id%3D2216%2Amarker%3D1673%2Afeatured%3D18019%2Ashow_banner_in_top_panel%3D1 .
Steffens, Britta et al. (2023) ‘Clinically practical pharmacometrics computer model to evaluate and personalize pharmacotherapy in pediatric rare diseases: application to Graves” disease’, Frontiers in Medicine, 10. Available at: https://doi.org/10.3389/fmed.2023.1099470.
Steffens, Britta et al. (2023) ‘Clinically practical pharmacometrics computer model to evaluate and personalize pharmacotherapy in pediatric rare diseases: application to Graves” disease’, Frontiers in Medicine, 10. Available at: https://doi.org/10.3389/fmed.2023.1099470.
Welzel, Tatjana, Aeschlimann, Florence and Woerner, Andreas (2023) ‘Autoinflammatorische Erkrankungen’, Rheuma Schweiz, n.a.(03), pp. 62–68.
Welzel, Tatjana, Aeschlimann, Florence and Woerner, Andreas (2023) ‘Autoinflammatorische Erkrankungen’, Rheuma Schweiz, n.a.(03), pp. 62–68.
Bräm DS et al. (2022) ‘Evaluation of machine learning methods for covariate data imputation in pharmacometrics’, CPT: Pharmacometrics and Systems Pharmacology, 11(12), pp. 1638–1648. Available at: https://doi.org/10.1002/psp4.12874.
Bräm DS et al. (2022) ‘Evaluation of machine learning methods for covariate data imputation in pharmacometrics’, CPT: Pharmacometrics and Systems Pharmacology, 11(12), pp. 1638–1648. Available at: https://doi.org/10.1002/psp4.12874.
Nahum U et al. (2022) ‘Machine learning-based algorithm as an innovative approach for the differentiation between diabetes insipidus and primary polydipsia in clinical practice’, European Journal of Endocrinology, 187(6), pp. 777–786. Available at: https://doi.org/10.1530/EJE-22-0368.
Nahum U et al. (2022) ‘Machine learning-based algorithm as an innovative approach for the differentiation between diabetes insipidus and primary polydipsia in clinical practice’, European Journal of Endocrinology, 187(6), pp. 777–786. Available at: https://doi.org/10.1530/EJE-22-0368.
Sauteur P.M.M. et al. (2022) ‘Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?’, The Lancet Microbe, 3(12), p. e897. Available at: https://doi.org/10.1016/S2666-5247(22)00190-2.
Sauteur P.M.M. et al. (2022) ‘Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?’, The Lancet Microbe, 3(12), p. e897. Available at: https://doi.org/10.1016/S2666-5247(22)00190-2.
Welzel T et al. (2022) ‘Tapering of biological treatment in autoinflammatory diseases: a scoping review’, Pediatric Rheumatology, 20(1), p. 67. Available at: https://doi.org/10.1186/s12969-022-00725-3.
Welzel T et al. (2022) ‘Tapering of biological treatment in autoinflammatory diseases: a scoping review’, Pediatric Rheumatology, 20(1), p. 67. Available at: https://doi.org/10.1186/s12969-022-00725-3.
Buettcher M. and Ritz N. (2022) ‘11/m—Pain in the left leg and limping after bicycle crash: Preparation for the medical specialist examination: part 92 11/m mit Schmerzen im linken Bein und Hinken nach Fahrradsturz: Vorbereitung auf die Facharztprüfung: Fall 92’, Monatsschrift fur Kinderheilkunde, 170, pp. 491–495. Available at: https://doi.org/10.1007/s00112-022-01602-9.
Buettcher M. and Ritz N. (2022) ‘11/m—Pain in the left leg and limping after bicycle crash: Preparation for the medical specialist examination: part 92 11/m mit Schmerzen im linken Bein und Hinken nach Fahrradsturz: Vorbereitung auf die Facharztprüfung: Fall 92’, Monatsschrift fur Kinderheilkunde, 170, pp. 491–495. Available at: https://doi.org/10.1007/s00112-022-01602-9.
Qin L et al. (2022) ‘Dyskalemia risk associated with fixed-dose anti-hypertensive medication combinations’, Journal of Human Hypertension. Epub 2021 Sep 23, 36(11), pp. 989–995. Available at: https://doi.org/10.1038/s41371-021-00600-w.
Qin L et al. (2022) ‘Dyskalemia risk associated with fixed-dose anti-hypertensive medication combinations’, Journal of Human Hypertension. Epub 2021 Sep 23, 36(11), pp. 989–995. Available at: https://doi.org/10.1038/s41371-021-00600-w.
Ziesenitz VC et al. (2022) ‘Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years’, Pediatric Drugs, 24(6), pp. 603–655. Available at: https://doi.org/10.1007/s40272-022-00514-1.
Ziesenitz VC et al. (2022) ‘Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years’, Pediatric Drugs, 24(6), pp. 603–655. Available at: https://doi.org/10.1007/s40272-022-00514-1.
Weber ANR et al. (2022) ‘Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3’, Rheumatology (United Kingdom), 61(10), pp. E299–E301. Available at: https://doi.org/10.1093/rheumatology/keac273.
Weber ANR et al. (2022) ‘Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3’, Rheumatology (United Kingdom), 61(10), pp. E299–E301. Available at: https://doi.org/10.1093/rheumatology/keac273.
Paioni, Paolo et al. (2022) ‘Swiss recommendations on perioperative antimicrobial prophylaxis in children’, Swiss Medical Weekly, 152(3738). Available at: https://doi.org/10.4414/SMW.2022.w30230.
Paioni, Paolo et al. (2022) ‘Swiss recommendations on perioperative antimicrobial prophylaxis in children’, Swiss Medical Weekly, 152(3738). Available at: https://doi.org/10.4414/SMW.2022.w30230.
Golhen K et al. (2022) ‘Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis’, Frontiers in Medicine, 9, p. 944208. Available at: https://doi.org/10.3389/fmed.2022.944208.
Golhen K et al. (2022) ‘Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis’, Frontiers in Medicine, 9, p. 944208. Available at: https://doi.org/10.3389/fmed.2022.944208.
Pfiffner, Miriam et al. (2022) ‘Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infants’, Archives of Disease in Childhood, 108(1), pp. 56–61. Available at: https://doi.org/10.1136/archdischild-2022-323807.
Pfiffner, Miriam et al. (2022) ‘Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infants’, Archives of Disease in Childhood, 108(1), pp. 56–61. Available at: https://doi.org/10.1136/archdischild-2022-323807.
Welzel T et al. (2022) ‘Vaccination completeness in children with rheumatic diseases: A longitudinal, observational multicenter cohort study in Switzerland’, Frontiers in Pediatrics, 10, p. 993811. Available at: https://doi.org/10.3389/fped.2022.993811.
Welzel T et al. (2022) ‘Vaccination completeness in children with rheumatic diseases: A longitudinal, observational multicenter cohort study in Switzerland’, Frontiers in Pediatrics, 10, p. 993811. Available at: https://doi.org/10.3389/fped.2022.993811.
Koch G et al. (2022) ‘Leveraging Predictive Pharmacometrics-Based Algorithms to Enhance Perinatal Care—Application to Neonatal Jaundice’, Frontiers in Pharmacology, 13, p. 842548. Available at: https://doi.org/10.3389/fphar.2022.842548.
Koch G et al. (2022) ‘Leveraging Predictive Pharmacometrics-Based Algorithms to Enhance Perinatal Care—Application to Neonatal Jaundice’, Frontiers in Pharmacology, 13, p. 842548. Available at: https://doi.org/10.3389/fphar.2022.842548.
Fabienne N. Jaeger et al. (2022) ‘Prise en charge médicale des réfugiés mineurs d’Ukraine’, Bull Med Suisses. 03.08.2022, (103(3132)), p. 3. Available at: https://doi.org/10.4414/bms.2022.20927.
Fabienne N. Jaeger et al. (2022) ‘Prise en charge médicale des réfugiés mineurs d’Ukraine’, Bull Med Suisses. 03.08.2022, (103(3132)), p. 3. Available at: https://doi.org/10.4414/bms.2022.20927.
Jger, F.N. et al. (2022) ‘Junge Flchtlinge optimal versorgen’, Schweizerische Ärztezeitung [Preprint]. Available at: https://doi.org/10.4414/saez.2022.20927.
Jger, F.N. et al. (2022) ‘Junge Flchtlinge optimal versorgen’, Schweizerische Ärztezeitung [Preprint]. Available at: https://doi.org/10.4414/saez.2022.20927.
Royston, Léna et al. (2022) ‘Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients’, Antimicrobial Agents and Chemotherapy, 66(8). Available at: https://doi.org/10.1128/aac.00657-22.
Royston, Léna et al. (2022) ‘Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients’, Antimicrobial Agents and Chemotherapy, 66(8). Available at: https://doi.org/10.1128/aac.00657-22.
Welzel T et al. (2022) ‘Variant in the PLCG2 Gene May Cause a Phenotypic Overlap of APLAID/PLAID: Case Series and Literature Review’, Journal of Clinical Medicine, 11(15). Available at: https://doi.org/10.3390/jcm11154369.
Welzel T et al. (2022) ‘Variant in the PLCG2 Gene May Cause a Phenotypic Overlap of APLAID/PLAID: Case Series and Literature Review’, Journal of Clinical Medicine, 11(15). Available at: https://doi.org/10.3390/jcm11154369.
Golhen K et al. (2022) ‘Value of Literature Review to Inform Development and Use of Biologics in Juvenile Idiopathic Arthritis’, 10. Available at: https://doi.org/10.3389/fped.2022.909118.
Golhen K et al. (2022) ‘Value of Literature Review to Inform Development and Use of Biologics in Juvenile Idiopathic Arthritis’, 10. Available at: https://doi.org/10.3389/fped.2022.909118.
Kapp, A. et al. (2022) ‘A red herring in an unusual presentation of a rare paediatric neuroborreliosis syndrome . Supplementum 258: Abstracts of the annual meeting 2022 of the Swiss Society of Paediatrics’, Swiss Medical Weekly, 152(2122), p. w30203. Available at: https://doi.org/10.4414/smw.2022.w30203.
Kapp, A. et al. (2022) ‘A red herring in an unusual presentation of a rare paediatric neuroborreliosis syndrome . Supplementum 258: Abstracts of the annual meeting 2022 of the Swiss Society of Paediatrics’, Swiss Medical Weekly, 152(2122), p. w30203. Available at: https://doi.org/10.4414/smw.2022.w30203.
Zimmermann P et al. (2022) ‘Neonates with SARS-CoV-2 infection: spectrum of disease from a prospective nationwide observational cohort study’, Swiss Medical Weekly, 152(21-22). Available at: https://doi.org/10.4414/SMW.2022.w30185.
Zimmermann P et al. (2022) ‘Neonates with SARS-CoV-2 infection: spectrum of disease from a prospective nationwide observational cohort study’, Swiss Medical Weekly, 152(21-22). Available at: https://doi.org/10.4414/SMW.2022.w30185.
Welzel T et al. (2022) ‘Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome—Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial’, Frontiers in Pediatrics, 10, p. 905046. Available at: https://doi.org/10.3389/fped.2022.905046.
Welzel T et al. (2022) ‘Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome—Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial’, Frontiers in Pediatrics, 10, p. 905046. Available at: https://doi.org/10.3389/fped.2022.905046.
Meyer Sauteur P.M. et al. (2022) ‘Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021’, Eurosurveillance, 27(19). Available at: https://doi.org/10.2807/1560-7917.ES.2022.27.19.2100746.
Meyer Sauteur P.M. et al. (2022) ‘Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021’, Eurosurveillance, 27(19). Available at: https://doi.org/10.2807/1560-7917.ES.2022.27.19.2100746.
Buettcher M (2022) ‘Borrelial lymphocytoma presentations of the ear’, Archives of Disease in Childhood, 107(5), p. 490. Available at: https://doi.org/10.1136/archdischild-2021-322652.
Buettcher M (2022) ‘Borrelial lymphocytoma presentations of the ear’, Archives of Disease in Childhood, 107(5), p. 490. Available at: https://doi.org/10.1136/archdischild-2021-322652.
Pfiffner, Miriam et al. (2022) ‘Pharmacometric Analysis of Intranasal and Intravenous Nalbuphine to Optimize Pain Management in Infants’, Frontiers in Pediatrics, 10. Available at: https://doi.org/10.3389/fped.2022.837492.
Pfiffner, Miriam et al. (2022) ‘Pharmacometric Analysis of Intranasal and Intravenous Nalbuphine to Optimize Pain Management in Infants’, Frontiers in Pediatrics, 10. Available at: https://doi.org/10.3389/fped.2022.837492.
Baumann, Philipp et al. (2022) ‘The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections’, PLoS ONE, 17(3 March). Available at: https://doi.org/10.1371/journal.pone.0264305.
Baumann, Philipp et al. (2022) ‘The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections’, PLoS ONE, 17(3 March). Available at: https://doi.org/10.1371/journal.pone.0264305.
Uka A et al. (2022) ‘Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study’, European Journal of Pediatrics, 181(3), pp. 1245–1255. Available at: https://doi.org/10.1007/s00431-021-04276-9.
Uka A et al. (2022) ‘Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study’, European Journal of Pediatrics, 181(3), pp. 1245–1255. Available at: https://doi.org/10.1007/s00431-021-04276-9.
Uka A et al. (2022) ‘Correction to: Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study (European Journal of Pediatrics, (2022), 181, 3, (1245-1255), 10.1007/s00431-021-04276-9)’, European Journal of Pediatrics, 181(3), p. 1257. Available at: https://doi.org/10.1007/s00431-021-04359-7.
Uka A et al. (2022) ‘Correction to: Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study (European Journal of Pediatrics, (2022), 181, 3, (1245-1255), 10.1007/s00431-021-04276-9)’, European Journal of Pediatrics, 181(3), p. 1257. Available at: https://doi.org/10.1007/s00431-021-04359-7.
Dao K et al. (2022) ‘Dosing strategies of imipenem in neonates based on pharmacometric modelling and simulation’, Journal of Antimicrobial Chemotherapy, 77(2), pp. 457–465. Available at: https://doi.org/10.1093/jac/dkab394.
Dao K et al. (2022) ‘Dosing strategies of imipenem in neonates based on pharmacometric modelling and simulation’, Journal of Antimicrobial Chemotherapy, 77(2), pp. 457–465. Available at: https://doi.org/10.1093/jac/dkab394.
Fröhlich GM et al. (2022) ‘Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19’, Eurosurveillance, 27(1). Available at: https://doi.org/10.2807/1560-7917.ES.2022.27.1.2001848.
Fröhlich GM et al. (2022) ‘Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19’, Eurosurveillance, 27(1). Available at: https://doi.org/10.2807/1560-7917.ES.2022.27.1.2001848.
Büttcher, M. et al. (2022) ‘Harnwegsinfektionen bei Kindern und Jugendlichen – Empfehlungen für Praxis und Klinik’, Padiatrische Praxis, 97, pp. 432–448.
Büttcher, M. et al. (2022) ‘Harnwegsinfektionen bei Kindern und Jugendlichen – Empfehlungen für Praxis und Klinik’, Padiatrische Praxis, 97, pp. 432–448.
Büttcher, M. et al. (2022) ‘Uninary tract infections in children and adolescents – recommendations for the general and hospital paediatrician/practitioner’, Internistische Praxis, 66, pp. 100–116.
Büttcher, M. et al. (2022) ‘Uninary tract infections in children and adolescents – recommendations for the general and hospital paediatrician/practitioner’, Internistische Praxis, 66, pp. 100–116.
Eugster NS et al. (2022) ‘Vaginale Geburt und niedriges Gestationsalter sind Hauptrisikofaktoren für Hypernatriämie bei Frühgeborenen < 32 SSW.’, Klinische Padiatrie, 234(1), pp. 20–25. Available at: https://doi.org/10.1055/a-1443-6208.
Eugster NS et al. (2022) ‘Vaginale Geburt und niedriges Gestationsalter sind Hauptrisikofaktoren für Hypernatriämie bei Frühgeborenen < 32 SSW.’, Klinische Padiatrie, 234(1), pp. 20–25. Available at: https://doi.org/10.1055/a-1443-6208.
Hofmann, D. et al. (2022) ‘Pharmacokinetic modelling and simulation to optimize albendazole dosing in hookworm- or Trichuris trichiura-infected infants to adults’, J Antimicrob Chemother, 77(4), pp. 1082–1093. Available at: https://doi.org/10.1093/jac/dkac020.
Hofmann, D. et al. (2022) ‘Pharmacokinetic modelling and simulation to optimize albendazole dosing in hookworm- or Trichuris trichiura-infected infants to adults’, J Antimicrob Chemother, 77(4), pp. 1082–1093. Available at: https://doi.org/10.1093/jac/dkac020.
Hofmann, D. et al. (2022) ‘Optimizing moxidectin dosing for Strongyloides stercoralis infections: insights from pharmacometric modeling’, Clin Transl Sci, 15(3), pp. 700–708. Available at: https://doi.org/10.1111/cts.13189.
Hofmann, D. et al. (2022) ‘Optimizing moxidectin dosing for Strongyloides stercoralis infections: insights from pharmacometric modeling’, Clin Transl Sci, 15(3), pp. 700–708. Available at: https://doi.org/10.1111/cts.13189.
Jaeger, F. N. et al. (2022) ‘Paediatric refugees from Ukraine: guidance for health care providers’, Swiss Med Wkly, 152(21-22), p. w30200. Available at: https://doi.org/10.4414/smw.2022.w30200.
Jaeger, F. N. et al. (2022) ‘Paediatric refugees from Ukraine: guidance for health care providers’, Swiss Med Wkly, 152(21-22), p. w30200. Available at: https://doi.org/10.4414/smw.2022.w30200.
Manduchi, Laura et al. (2022) ‘A DEEP VARIATIONAL APPROACH TO CLUSTERING SURVIVAL DATA’. International Conference on Learning Representations, ICLR.
Manduchi, Laura et al. (2022) ‘A DEEP VARIATIONAL APPROACH TO CLUSTERING SURVIVAL DATA’. International Conference on Learning Representations, ICLR.
Samiee-Zafarghandy S et al. (2022) ‘Novel strategy to personalise use of ibuprofen for closure of patent ductus arteriosus in preterm neonates’, Archives of Disease in Childhood, 107(1), pp. 86–91. Available at: https://doi.org/10.1136/archdischild-2020-321381.
Samiee-Zafarghandy S et al. (2022) ‘Novel strategy to personalise use of ibuprofen for closure of patent ductus arteriosus in preterm neonates’, Archives of Disease in Childhood, 107(1), pp. 86–91. Available at: https://doi.org/10.1136/archdischild-2020-321381.
Smit, C. et al. (2022) ‘Characterization of the population pharmacokinetics of moxidectin in adults infected with strongyloides stercoralis: support for a fixed-dose treatment regimen’, Clinical pharmacokinetics, 61(1), pp. 123–132. Available at: https://doi.org/10.1007/s40262-021-01048-4.
Smit, C. et al. (2022) ‘Characterization of the population pharmacokinetics of moxidectin in adults infected with strongyloides stercoralis: support for a fixed-dose treatment regimen’, Clinical pharmacokinetics, 61(1), pp. 123–132. Available at: https://doi.org/10.1007/s40262-021-01048-4.
Smit, C. et al. (2022) ‘Steering away from current amoxicillin dose reductions in hospitalized patients with impaired kidney function to avoid subtherapeutic drug exposure’, Antibiotics (Basel), 11(9), p. 1190. Available at: https://doi.org/10.3390/antibiotics11091190.
Smit, C. et al. (2022) ‘Steering away from current amoxicillin dose reductions in hospitalized patients with impaired kidney function to avoid subtherapeutic drug exposure’, Antibiotics (Basel), 11(9), p. 1190. Available at: https://doi.org/10.3390/antibiotics11091190.
Ternant D et al. (2022) ‘Infliximab Treatment Does Not Lead to Full TNF-α Inhibition: A Target-Mediated Drug Disposition Model’, Clinical Pharmacokinetics, 61(1), pp. 143–154. Available at: https://doi.org/10.1007/s40262-021-01057-3.
Ternant D et al. (2022) ‘Infliximab Treatment Does Not Lead to Full TNF-α Inhibition: A Target-Mediated Drug Disposition Model’, Clinical Pharmacokinetics, 61(1), pp. 143–154. Available at: https://doi.org/10.1007/s40262-021-01057-3.
A Kapp et al. (2022) ‘A red herring in an unusual presentation of a rare paediatric neuroborreliosis syndrome’, in EMH SWISS MEDICAL PUBLISHERS LTD (ed.) Pädiatrie Schweiz. Luzern: Swiss Medical Weekly (Pädiatrie Schweiz), p. 1.
A Kapp et al. (2022) ‘A red herring in an unusual presentation of a rare paediatric neuroborreliosis syndrome’, in EMH SWISS MEDICAL PUBLISHERS LTD (ed.) Pädiatrie Schweiz. Luzern: Swiss Medical Weekly (Pädiatrie Schweiz), p. 1.
Büttcher M et al. (2022) ‘Harnwegsinfektionen bei Kindern und Jugendlichen – Empfehlungen für Praxis und Klinik’, Pädiatrische Praxis, (Band 97/3), pp. 432–448.
Büttcher M et al. (2022) ‘Harnwegsinfektionen bei Kindern und Jugendlichen – Empfehlungen für Praxis und Klinik’, Pädiatrische Praxis, (Band 97/3), pp. 432–448.
Büttcher M et al. (2022) ‘Harnwegsinfektionen bei Kindern und Jugendlichen – Empfehlungen für Praxis und Klinik’, Internistische Praxis [Preprint], (Band 066/01).
Büttcher M et al. (2022) ‘Harnwegsinfektionen bei Kindern und Jugendlichen – Empfehlungen für Praxis und Klinik’, Internistische Praxis [Preprint], (Band 066/01).
Otto M et al. (2022) ‘Semi- Mechanistic Modeling of Copeptin and Aldosterone Kinetics and Dynamics in Response to Rehydration Treatment for Diabetic Ketoacidosis in Children’, CPT: Pharmacometrics & Systems Pharmacology [Preprint], (PSP -2022-0079R1).
Otto M et al. (2022) ‘Semi- Mechanistic Modeling of Copeptin and Aldosterone Kinetics and Dynamics in Response to Rehydration Treatment for Diabetic Ketoacidosis in Children’, CPT: Pharmacometrics & Systems Pharmacology [Preprint], (PSP -2022-0079R1).
Heyne-Pietschmann M et al. (2021) ‘Newborns with Bloody Stools—At the Crossroad between Efficient Management of Necrotizing Enterocolitis and Antibiotic Stewardship’, Antibiotics, 10(12). Available at: https://doi.org/10.3390/antibiotics10121467.
Heyne-Pietschmann M et al. (2021) ‘Newborns with Bloody Stools—At the Crossroad between Efficient Management of Necrotizing Enterocolitis and Antibiotic Stewardship’, Antibiotics, 10(12). Available at: https://doi.org/10.3390/antibiotics10121467.
Welzel T et al. (2021) ‘Colchicine – an effective treatment for children with a clinical diagnosis of autoinflammatory diseases without pathogenic gene variants’, Pediatric Rheumatology, 19(1), p. 142. Available at: https://doi.org/10.1186/s12969-021-00588-0.
Welzel T et al. (2021) ‘Colchicine – an effective treatment for children with a clinical diagnosis of autoinflammatory diseases without pathogenic gene variants’, Pediatric Rheumatology, 19(1), p. 142. Available at: https://doi.org/10.1186/s12969-021-00588-0.
Welzel T et al. (2021) ‘Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials’, Pediatric Rheumatology, 19(1), p. 46. Available at: https://doi.org/10.1186/s12969-021-00514-4.
Welzel T et al. (2021) ‘Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials’, Pediatric Rheumatology, 19(1), p. 46. Available at: https://doi.org/10.1186/s12969-021-00514-4.
Welzel T et al. (2021) ‘Correction to: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials (Pediatric Rheumatology, (2021), 19, 1, (46), 10.1186/s12969-021-00514-4)’, 19(1). Available at: https://doi.org/10.1186/s12969-021-00593-3.
Welzel T et al. (2021) ‘Correction to: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials (Pediatric Rheumatology, (2021), 19, 1, (46), 10.1186/s12969-021-00514-4)’, 19(1). Available at: https://doi.org/10.1186/s12969-021-00593-3.
Welzel T et al. (2021) ‘Colchicine Effectiveness and Safety in Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis’, Frontiers in Pediatrics, 9, p. 759664. Available at: https://doi.org/10.3389/fped.2021.759664.
Welzel T et al. (2021) ‘Colchicine Effectiveness and Safety in Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis’, Frontiers in Pediatrics, 9, p. 759664. Available at: https://doi.org/10.3389/fped.2021.759664.
Koch, Gilbert et al. (2021) ‘Modeling of levothyroxine in newborns and infants with congenital hypothyroidism: challenges and opportunities of a rare disease multi-center study’, Journal of Pharmacokinetics and Pharmacodynamics, 48(5), pp. 711–723. Available at: https://doi.org/10.1007/s10928-021-09765-w.
Koch, Gilbert et al. (2021) ‘Modeling of levothyroxine in newborns and infants with congenital hypothyroidism: challenges and opportunities of a rare disease multi-center study’, Journal of Pharmacokinetics and Pharmacodynamics, 48(5), pp. 711–723. Available at: https://doi.org/10.1007/s10928-021-09765-w.
Roelens, M. et al. (2021) Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR). Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2021.09.14.21263153.
Roelens, M. et al. (2021) Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR). Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2021.09.14.21263153.
von Hammerstein AL et al. (2021) ‘Interseasonal rsv infections in switzerland - rapid establishment of a clinician-led national reporting system (rsv epich)’, Swiss Medical Weekly, 151(35-36), p. w30057. Available at: https://doi.org/10.4414/SMW.2021.w30057.
von Hammerstein AL et al. (2021) ‘Interseasonal rsv infections in switzerland - rapid establishment of a clinician-led national reporting system (rsv epich)’, Swiss Medical Weekly, 151(35-36), p. w30057. Available at: https://doi.org/10.4414/SMW.2021.w30057.
Gotta V et al. (2021) ‘Hemodialysis (HD) dose and ultrafiltration rate are associated with survival in pediatric and adolescent patients on chronic HD—a large observational study with follow-up to young adult age’, Pediatric Nephrology, 36(8), pp. 2421–2432. Available at: https://doi.org/10.1007/s00467-021-04972-6.
Gotta V et al. (2021) ‘Hemodialysis (HD) dose and ultrafiltration rate are associated with survival in pediatric and adolescent patients on chronic HD—a large observational study with follow-up to young adult age’, Pediatric Nephrology, 36(8), pp. 2421–2432. Available at: https://doi.org/10.1007/s00467-021-04972-6.
Tortorici MA et al. (2021) ‘Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy’, CPT: Pharmacometrics and Systems Pharmacology, 10(8), pp. 839–850. Available at: https://doi.org/10.1002/psp4.12647.
Tortorici MA et al. (2021) ‘Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy’, CPT: Pharmacometrics and Systems Pharmacology, 10(8), pp. 839–850. Available at: https://doi.org/10.1002/psp4.12647.
Welzel T, Donner B and van den Anker JN (2021) ‘Intrauterine growth retardation in pregnant women with long QT syndrome treated with beta-receptor blockers’, Neonatology, 118(4), pp. 406–415. Available at: https://doi.org/10.1159/000516845.
Welzel T, Donner B and van den Anker JN (2021) ‘Intrauterine growth retardation in pregnant women with long QT syndrome treated with beta-receptor blockers’, Neonatology, 118(4), pp. 406–415. Available at: https://doi.org/10.1159/000516845.
Zihlmann-Ji J et al. (2021) ‘Reduction of Duration of Antibiotic Therapy for Suspected Early-Onset Sepsis in Late-Preterm and Term Newborns After Implementation of a Procalcitonin-Guided Algorithm: A Population-Based Study in Central Switzerland’, Frontiers in Pediatrics, 9, p. 702133. Available at: https://doi.org/10.3389/fped.2021.702133.
Zihlmann-Ji J et al. (2021) ‘Reduction of Duration of Antibiotic Therapy for Suspected Early-Onset Sepsis in Late-Preterm and Term Newborns After Implementation of a Procalcitonin-Guided Algorithm: A Population-Based Study in Central Switzerland’, Frontiers in Pediatrics, 9, p. 702133. Available at: https://doi.org/10.3389/fped.2021.702133.
Maximiano Sousa F et al. (2021) ‘Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: Prospective observational cohort study’, Swiss Medical Weekly, 151(29-30), p. w20547. Available at: https://doi.org/10.4414/smw.2021.20547.
Maximiano Sousa F et al. (2021) ‘Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: Prospective observational cohort study’, Swiss Medical Weekly, 151(29-30), p. w20547. Available at: https://doi.org/10.4414/smw.2021.20547.
Deichmann, J. et al. (2021) A Comprehensive Model of Glucose-Insulin Regulation Including Acute and Prolonged Effects of Physical Activity in Type 1 Diabetes. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2021.06.09.447693.
Deichmann, J. et al. (2021) A Comprehensive Model of Glucose-Insulin Regulation Including Acute and Prolonged Effects of Physical Activity in Type 1 Diabetes. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2021.06.09.447693.
Koch G et al. (2021) ‘The rhythm of a preterm neonate’s life: ultradian oscillations of heart rate, body temperature and sleep cycles’, Journal of Pharmacokinetics and Pharmacodynamics, 48(3), pp. 401–410. Available at: https://doi.org/10.1007/s10928-020-09735-8.
Koch G et al. (2021) ‘The rhythm of a preterm neonate’s life: ultradian oscillations of heart rate, body temperature and sleep cycles’, Journal of Pharmacokinetics and Pharmacodynamics, 48(3), pp. 401–410. Available at: https://doi.org/10.1007/s10928-020-09735-8.
Maringwa J et al. (2021) ‘Characterizing Effects of Antidiabetic Drugs on Heart Rate, Systolic and Diastolic Blood Pressure’, Clinical Pharmacology and Therapeutics, 109(6), pp. 1583–1592. Available at: https://doi.org/10.1002/cpt.2130.
Maringwa J et al. (2021) ‘Characterizing Effects of Antidiabetic Drugs on Heart Rate, Systolic and Diastolic Blood Pressure’, Clinical Pharmacology and Therapeutics, 109(6), pp. 1583–1592. Available at: https://doi.org/10.1002/cpt.2130.
Zheng B et al. (2021) ‘Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A-I and cholesterol efflux capacity in acute myocardial infarction patients’, British Journal of Clinical Pharmacology, 87(6), pp. 2558–2571. Available at: https://doi.org/10.1111/bcp.14666.
Zheng B et al. (2021) ‘Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A-I and cholesterol efflux capacity in acute myocardial infarction patients’, British Journal of Clinical Pharmacology, 87(6), pp. 2558–2571. Available at: https://doi.org/10.1111/bcp.14666.
Buettcher M and Imbimbo C (2021) ‘Ulceroglandular tularemia’, New England Journal of Medicine, 384(14), p. 1349. Available at: https://doi.org/10.1056/NEJMicm2031676.
Buettcher M and Imbimbo C (2021) ‘Ulceroglandular tularemia’, New England Journal of Medicine, 384(14), p. 1349. Available at: https://doi.org/10.1056/NEJMicm2031676.
Bachmann F et al. (2021) ‘OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control’, Journal of Optimization Theory and Applications, 189(1), pp. 46–65. Available at: https://doi.org/10.1007/s10957-021-01819-w.
Bachmann F et al. (2021) ‘OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control’, Journal of Optimization Theory and Applications, 189(1), pp. 46–65. Available at: https://doi.org/10.1007/s10957-021-01819-w.